| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.97B | $2.05B | $2.08B |
| YoY Revenue Growth % | -3.9% | -1.5% | — |
| Gross Profit | $598.1M | $627.1M | — |
| Gross Margin % | 30.4% | 30.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $143.1M | $170.2M | $192.4M |
| Operating Margin % | 7.3% | 8.3% | 9.3% |
| Net Income (GAAP) | $98.7M | $109.3M | $118.5M |
| EBITDA (Normalized) | $214.3M | $256.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $208.3M | $277.1M | $257.9M |
| Capital Expenditures (CapEx) | $89.0M | $107.6M | — |
| Free Cash Flow (FCF) | $119.4M | $169.5M | $257.9M |
| FCF Margin % | 6.1% | 8.3% | 12.4% |
| Return on Invested Capital (ROIC %) | 9.5% | 12.2% | — |
| Cash & Short-Term Equivalents | $129.3M | $121.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.32B | $1.22B | — |